FDA seeks input on new rare disease drug development framework The FDA is seeking public feedback on plans to tailor rare disease drug development and regulatory review to small patient populations and the evidence they can realistically generate. New fra... See more
Cabenuva real-world study reports sustained HIV viral suppression A US observational study of nearly 7,000 adults with HIV-1 found high rates of viral suppression and continued treatment after switching to long-acting injectable Cabenuva. Real-world study... See more
AmplexDiagnostics launches rapid Candida auris resistance test AmplexDiagnostics has launched a CE-IVD molecular diagnostic test that detects a genetic mutation associated with antifungal resistance in Candidozyma auris, a multidrug-resistant yeast pathog... See more
SeaBeLife secures €2.9m to advance acute liver injury drug SeaBeLife has secured €2.9 million in French government funding to advance SBL01, an experimental drug candidate for acute liver injury, towards clinical trials. The funding will support the SeaBe... See more
Gesynta Pharma completes recruitment in endometriosis trial Gesynta Pharma has completed recruitment for its Phase 2 trial of vipoglanstat in endometriosis, with results expected in the second quarter of 2027. The NOVA trial has randomised 213 participant... See more
